arrow
K

Kim Taubman

radiology
H指数:14
被引数:2,386

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial

中高危前列腺癌男性68Ga-PSMA-11正电子发射断层扫描/计算机断层扫描的基线淋巴结状态是治疗失败的预后因素: proPSMA试验的随访

2024-11-290
OAAI
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)

氟18标记的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描或磁共振成像诊断和定位前列腺癌。前瞻性单臂配对比较 (PEDAL)

2024-10-011
OA
Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society
2021-12-214
OA
Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society
2021-12-193
OA
Patterns of disease detection using [18F]DCFPyL PET/CT imaging in patients with detectable PSA post prostatectomy being considered for salvage radiotherapy: a prospective trial
2021-04-1417
OAAI
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

高危前列腺癌患者行根治性手术或放疗前的前列腺特异性膜抗原pet-ct (proPSMA): 一项前瞻性、随机、多中心研究

LANCET
IF88.5
2020-04-011.2K
PREAI